Efficacy and tolerance of dupilumab in patients with moderate-to-severe atopic dermatitis and obesity

被引：0

作者：

Dupuis, Josephine ^{[1
]}

Tauber, Marie ^{[2
,3
]}

Mahe, Emmanuel ^{[4
]}

Jachiet, Marie ^{[5
]}

Soria, Angele ^{[6
]}

Tetart, Florence ^{[7
]}

Puzenat, Eve ^{[8
]}

Pasteur, Justine ^{[9
]}

Raison-Peyron, Nadia ^{[10
]}

Giordano-Labadie, Francoise ^{[11
]}

Droitcourt, Catherine ^{[12
]}

Leleu, Camille ^{[13
]}

Nosbaum, Audrey ^{[3
]}

Aubert, Helene ^{[14
]}

Moigne, Marie L. E. ^{[14
]}

Bernier, Claire ^{[14
]}

Barbarot, Sebastien ^{[15
]}

Ezzedine, Khaled ^{[16
]}

Diaz, Emmanuelle ^{[16
]}

Hubiche, Thomas ^{[17
]}

Faiz, Sarah ^{[18
]}

Azib, Selma ^{[1
]}

Dezoteux, Frederic ^{[1
,19
]}

Chosidow, Olivier ^{[20
]}

Staumont-Salle, Delphine ^{[1
,19
]}

机构：

[1] CHU Lille, Serv Dermatol, F-59037 Lille, France

[2] CHU Toulouse, Hop Larrey, Serv Dermatol, Toulouse, France

[3] Hop Lyon Sud, Allergol & Immunol Clin, CIRI Inserm U1111, Lyon, France

[4] Hop Victor Dupouy, Serv Dermatol, Argenteuil, France

[5] Hop St Louis, Dermatol, AP HP, Paris, France

[6] Hop Tenon, AP HP, Dermatol & Allergol, Paris, France

[7] CHU Rouen, Dermatol, Rouen, France

[8] CHU Besancon, Dermatol, Besancon, France

[9] CHU Clermont Ferrand, Dermatol, Clermont Ferrand, France

[10] CHU Montpellier, Dermatol, Montpellier, France

[11] CHU Toulouse, Dermatol, Toulouse, France

[12] Univ Rennes, Irset Inst Rech Sante, Dept Dermatol, CHU Rennes,Inserm,EHESP,UMR S 1085, Rennes, France

[13] Hop Bocage, Dermatol, Dijon, France

[14] CHU Nantes, Dermatol, Nantes, France

[15] Nantes Univ, Dept Dermatol, CHU Nantes, INRAE,UMR 1280,PhAN, Nantes, France

[16] Hop Henri Mondor, AP HP, Dermatol, Creteil, France

[17] Hop Archet 2, Dermatol, Nice, France

[18] CH Douai, Dermatol, Douai, France

[19] Univ Lille, Lille Inflammat Translat Res Inst INFINITE, INSERM U1286, Lille, France

[20] Univ Hosp La Pitie Salpetriere, AP HP, Facial Dermatosis Clin, Paris, France

来源：

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY | 2024年

关键词：

D O I：

10.1111/jdv.20264

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

引用

页数：5

共 50 条

[41] Tear fluid dupilumab levels of patients with moderate-to-severe atopic dermatitis and ocular surface disease
Achten, R.
Thijs, J.
van Luijk, C.
van Wijk, F.
van Luin, M.
El Amrani, M.
Delemarre, E.
de Graaf, M.
Bakker, D.
de Boer, J.
de Bruin-Weller, M.
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2022, 142 (12) : S196 - S196
[42] Real-life effectiveness and safety of dupilumab in adult patients with moderate-to-severe atopic dermatitis
Salman, Andac
Sengun, Ozlem Apti
Aktas, Meryem
Taskapan, Oktay
DERMATOLOGIC THERAPY, 2022, 35 (01)
[43] Sexual dysfunction in a cohort of patients with moderate-to-severe atopic dermatitis. Influence of dupilumab treatment
Linares-Gonzalez, Laura
Lozano-Lozano, Ignacio
Gutierrez-Rojas, Luis
Ruiz-Villaverde, Ricardo
Lozano-Lozano, Mario
INTERNATIONAL JOURNAL OF DERMATOLOGY, 2022, 61 (05) : 607 - 610
[44] Efficacy and Safety of Upadacitinib vs Dupilumab in Adults With Moderate-to-Severe Atopic Dermatitis A Randomized Clinical Trial
Blauvelt, Andrew
Teixeira, Henrique D.
Simpson, Eric L.
Costanzo, Antonio
De Bruin-Weller, Marjolein
Barbarot, Sebastien
Prajapati, Vimal H.
Lio, Peter
Hu, Xiaofei
Wu, Tianshuang
Liu, John
Ladizinski, Barry
Chu, Alvina D.
Eyerich, Kilian
JAMA DERMATOLOGY, 2021, 157 (09) : 1047 - 1055
[45] Ophthalmological characteristics and treatment outcomes of conjunctivitis in patients receiving dupilumab for moderate-to-severe atopic dermatitis
Lans, A.
Van Luijk, C. M.
Bakker, D. S.
Ariens, L. F. M.
Thijs, J. L.
Van der Schaft, J.
De Boer, J. H.
Knol, E. F.
De Bruin-Weller, M. S.
Balak, D. M. W.
ALLERGY, 2019, 74 : 714 - 714
[46] Real-world experience of dupilumab in the treatment of moderate-to-severe atopic dermatitis
Kim, Nicole S.
Maliyar, Khalad
Oliveira, Luciana
O'Toole, Ashley
Gooderham, Melinda J.
INTERNATIONAL JOURNAL OF DERMATOLOGY, 2020, 59 (10) : E361 - E363
[47] Moderate-to-severe atopic dermatitis in different age groups treated with dupilumab in China
Song, Xiaoting
Liu, Bo
Luan, Tingting
Liao, Shuanglu
Tan, Yen
Peng, Chengyue
Zhao, Zuotao
ALLERGY, 2023, 78 (06) : 1696 - 1699
[48] Switching from Dupilumab to Abrocitinib in Patients With Moderate-to-Severe Atopic Dermatitis: A Post Hoc Analysis of Efficacy After Treatment With Dupilumab in JADE DARE
Jonathan I. Silverberg
Eric L. Simpson
Andrew E. Pink
Stephan Weidinger
Gary Chan
Pinaki Biswas
Claire Clibborn
Erman Güler
Dermatology and Therapy, 2025, 15 (2) : 367 - 380
[49] Efficacy and safety of abrocitinib in patients with moderate-to-severe atopic dermatitis and comorbid allergies
Schmid-Grendelmeier, Peter
Gooderham, Melinda J.
Hartmann, Karin
Konstantinou, George N.
Fellmann, Marc
Koulias, Christopher
Clibborn, Claire
Biswas, Pinaki
Brunner, Patrick M.
ALLERGY, 2024, 79 (01) : 174 - 183
[50] Dupilumab (Dupixent) for Moderate to Severe Atopic Dermatitis
不详
MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2017, 59 (1519): : 64 - 66

← 1 2 3 4 5 →